Late postnatal systemic steroids predispose to retinopathy of prematurity in very‐low‐birth‐weight infants: a comparative study

Background and objective: Retinopathy of prematurity (ROP) develops mostly in very‐low‐birth‐weight (VLBW) premature infants. Besides prematurity and hyperoxia, other variables have been brought up as risk factors for ROP. We aimed to search risk factors for ROP by comparing two groups of preemies, one with and the other without ROP.

[1]  D. Clark,et al.  An unusual case of retinopathy of prematurity , 2007, Journal of Perinatology.

[2]  S. Majzoub,et al.  Étude épidémiologique de la rétinopathie du prématuré : les facteurs de risque au CHU de Tours , 2007 .

[3]  L. Ment,et al.  Genetic Susceptibility to Retinopathy of Prematurity , 2006, Pediatrics.

[4]  M. Hartnett,et al.  Triamcinolone reduces neovascularization, capillary density and IGF-1 receptor phosphorylation in a model of oxygen-induced retinopathy. , 2006, Investigative ophthalmology & visual science.

[5]  H. Modanlou,et al.  Ontogeny of VEGF, IGF-I, and GH in neonatal rat serum, vitreous fluid, and retina from birth to weaning. , 2006, Investigative ophthalmology & visual science.

[6]  J. Holmes,et al.  The Relationship of Retinal VEGF and Retinal IGF-1 mRNA with Neovascularization in an Acidosis-Induced Model of Retinopathy of Prematurity , 2006, Current eye research.

[7]  O. Genzel‐Boroviczény,et al.  Mortality and major morbidity in premature infants less than 31 weeks gestational age in the decade after introduction of surfactant , 2006, Acta obstetricia et gynecologica Scandinavica.

[8]  T. Ertl,et al.  Relationship between Hyperglycemia and Retinopathy of Prematurity in Very Low Birth Weight Infants , 2006, Neonatology.

[9]  P. Karna,et al.  Retinopathy of prematurity and risk factors: a prospective cohort study , 2005, BMC pediatrics.

[10]  N. Evans,et al.  Prenatal Risk Factors for Severe Retinopathy of Prematurity Among Very Preterm Infants of the Australian and New Zealand Neonatal Network , 2005, Pediatrics.

[11]  B. Thomas,et al.  The efficacy of playing a virtual reality game in modulating pain for children with acute burn injuries: A randomized controlled trial [ISRCTN87413556] , 2005, BMC pediatrics.

[12]  Yi-Hsin Yang,et al.  Risk Factors of Retinopathy of Prematurity in Premature Infants Weighing Less Than 1600 g , 2005, American journal of perinatology.

[13]  J. Sohn,et al.  Postnatal risk factors of retinopathy of prematurity. , 2004, Paediatric and perinatal epidemiology.

[14]  A. Lusky,et al.  Excess mortality and morbidity among small-for-gestational-age premature infants: a population-based study. , 2003, The Journal of pediatrics.

[15]  S. Laroche,et al.  Early use of high frequency ventilation in the premature neonate , 2003, European Journal of Pediatrics.

[16]  R. Ehrenkranz,et al.  Early postnatal (<96 hours) corticosteroids for preventing chronic lung disease in preterm infants. , 2003, The Cochrane database of systematic reviews.

[17]  R. Ehrenkranz,et al.  Delayed (>3 weeks) postnatal corticosteroids for chronic lung disease in preterm infants. , 2003, The Cochrane database of systematic reviews.

[18]  C. Romagnoli,et al.  Effects of early dexamethasone therapy on pulmonary fibrogenic mediators and respiratory mechanics in preterm infants. , 2002, European cytokine network.

[19]  Leh Smith.  Pathogenesis of retinopathy of prematurity , 2002, Acta paediatrica (Oslo, Norway : 1992). Supplement.

[20]  J. Holmes,et al.  Duration of acidosis and recovery determine preretinal neovascularization in the rat model of acidosis-induced retinopathy , 2002, Current eye research.

[21]  L. Doyle,et al.  Perinatal glucocorticoid therapy and neurodevelopmental outcome: an epidemiologic perspective. , 2001, Seminars in neonatology : SN.

[22]  R. Watkins,et al.  Expression of Vascular Endothelial Growth Factor and Flk-1 in Developing and Glucocorticoid-Treated Mouse Lung , 2000, Pediatric Research.

[23]  C. D’Angio,et al.  Vascular Endothelial Growth Factor in Pulmonary Lavage Fluid from Premature Infants: Effects of Age and Postnatal Dexamethasone , 1999, Neonatology.

[24]  J. Holmes,et al.  Metabolic acidosis-induced retinopathy in the neonatal rat. , 1999, Investigative ophthalmology & visual science.

[25]  J. Holmes,et al.  Carbon dioxide-induced retinopathy in the neonatal rat. , 1998, Current eye research.

[26]  M. Battin,et al.  Growth and growth factors in premature infants receiving dexamethasone for bronchopulmonary dysplasia. , 1997, American journal of perinatology.

[27]  P. Karna,et al.  EFFECT OF ANTENATAL AND POSTNATAL GLUCOCORTICOIDS (PG) ON THE SEVERITY OF RETINOPATHY OF PREMATURITY (ROP). 1144 , 1996, Pediatric Research.

[28]  P. Pisella,et al.  [Epidemiology for retinopathy of prematurity: risk factors in the Tours hospital (France)]. , 2007, Journal Francais d'Ophtalmologie.

[29]  M. Mostert,et al.  Fungal and bacterial sepsis and threshold ROP in preterm very low birth weight neonates , 2006, Journal of Perinatology.

[30]  R. Saunders,et al.  The Effect of Anemia on Retinopathy of Prematurity in Extremely Low Birth Weight Infants , 2001, Journal of Perinatology.

[31]  Jacqueline Termote1,et al.  DO POSTNATAL GLUCOCORTICOIDS AND RETINOPATHY OF PREMATURITY RELATE? , 2000, American journal of perinatology.